Mitchell Sinkler & Starr/PA has filed a Form 13F-HR report disclosing its equity portfolio as of the close of business on September 30, 2026. The filing lists the firm's total holdings as 155 positions, with a total value of approximately $2.467 billion.
The portfolio is heavily weighted toward large-cap technology and healthcare companies. The top individual holding is Microsoft Corporation, for which the firm holds 13,193,133 shares valued at $25,723,000. Other significant positions include NVIDIA Corporation with 11,759,971 shares valued at $51,493,000, and Procter & Gamble Co. with 7,500,180 shares valued at $51,626,000.
Healthcare names such as Merck & Co. Inc. and Johnson & Johnson appear prominently, with the firm holding 6,185,992 and 5,658,288 shares, respectively. The filing also lists substantial stakes in Visa Inc., Eli Lilly & Co., and JPMorgan Chase & Co.
In addition to individual equities, the portfolio includes a significant allocation to exchange-traded funds (ETFs). The firm holds shares in the Vanguard S&P 500 ETF, the Schwab Strategic Trust US Large Cap ETF, and the Vanguard World Fund Inf Tech ETF, among others.
